HRT FINANCIAL LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 259 filers reported holding HAEMONETICS CORP in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2022$3,393
-99.9%
43,145
-22.8%
0.05%
+20.0%
Q2 2022$3,642,000
+514.2%
55,878
+399.0%
0.04%
+1233.3%
Q4 2021$593,000
-67.6%
11,197
-32.1%
0.00%
-84.2%
Q1 2021$1,829,000
-46.2%
16,485
-56.6%
0.02%
-81.4%
Q2 2020$3,402,000
+186.4%
37,989
+267.3%
0.10%
+100.0%
Q4 2019$1,188,000
-17.4%
10,342
-9.3%
0.05%
-25.0%
Q3 2019$1,438,000
+95.6%
11,402
+35.6%
0.07%
-40.4%
Q1 2019$735,0008,4080.11%
Other shareholders
HAEMONETICS CORP shareholders Q2 2021
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders